202 related articles for article (PubMed ID: 17101549)
1. Tetranectin in cerebrospinal fluid of patients with multiple sclerosis.
Stoevring B; Jaliashvili I; Thougaard AV; Ensinger C; Høgdall CK; Rasmussen LS; Sellebjerg F; Christiansen M
Scand J Clin Lab Invest; 2006; 66(7):577-83. PubMed ID: 17101549
[TBL] [Abstract][Full Text] [Related]
2. Tetranectin in cerebrospinal fluid: biochemical characterisation and evidence of intrathecal synthesis or selective uptake into CSF.
Stoevring B; Jaliashvili I; Thougaard AV; Ensinger C; Høgdall CK; Rasmussen LS; Sellebjerg F; Christiansen M
Clin Chim Acta; 2005 Sep; 359(1-2):65-71. PubMed ID: 15901484
[TBL] [Abstract][Full Text] [Related]
3. Tetranectin is a potential biomarker in cerebrospinal fluid and serum of patients with epilepsy.
Wang L; Pan Y; Chen D; Xiao Z; Xi Z; Xiao F; Wang X
Clin Chim Acta; 2010 Apr; 411(7-8):581-3. PubMed ID: 20102706
[TBL] [Abstract][Full Text] [Related]
4. [Findings of cerebrospinal fluid in the diagnosis of multiple sclerosis].
Drulović J; Stojsavljević N; Dujmović I; Sokić D; Mavra M; Lević Z
Srp Arh Celok Lek; 1995; 123(7-8):191-3. PubMed ID: 17974427
[TBL] [Abstract][Full Text] [Related]
5. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis.
Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D
J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662
[TBL] [Abstract][Full Text] [Related]
6. Soluble interleukin-6 receptor (sIL-6R) in cerebrospinal fluid of patients with inflammatory and non inflammatory neurological diseases.
Michalopoulou M; Nikolaou C; Tavernarakis A; Alexandri NM; Rentzos M; Chatzipanagiotou S; Cambouri C; Vassilopoulos D
Immunol Lett; 2004 Jul; 94(3):183-9. PubMed ID: 15275965
[TBL] [Abstract][Full Text] [Related]
7. Th1/Th2 cytokine balance and nitric oxide in cerebrospinal fluid and serum from patients with multiple sclerosis.
Rodríguez-Sáinz Mdel C; Sánchez-Ramón S; de Andrés C; Rodríguez-Mahou M; Muñoz-Fernández MA
Eur Cytokine Netw; 2002; 13(1):110-4. PubMed ID: 11956029
[TBL] [Abstract][Full Text] [Related]
8. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
Chowdhury SA; Lin J; Sadiq SA
Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
[TBL] [Abstract][Full Text] [Related]
9. [Cytoimmunological profile of cerebrospinal fluid in diagnosis of multiple sclerosis].
Caudie C; Birouk AM; Bancel J; Claudy D; Gignoux L; Vukusic S; Confavreux C
Pathol Biol (Paris); 2005 Mar; 53(2):68-74. PubMed ID: 15708649
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid and plasma apolipoproteins in patients with multiple sclerosis.
Gelman BB; Rifai N; Christenson RH; Silverman LM
Ann Clin Lab Sci; 1988; 18(1):46-52. PubMed ID: 3355096
[TBL] [Abstract][Full Text] [Related]
11. Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG.
Bartosik-Psujek H; Archelos JJ
J Neurol; 2004 Apr; 251(4):414-20. PubMed ID: 15083285
[TBL] [Abstract][Full Text] [Related]
12. Soluble interleukin-2 receptors in cerebrospinal fluid from individuals with various neurological disorders.
Kittur SD; Kittur DS; Soncrant TT; Rapoport SI; Tourtellotte WW; Nagel JE; Adler WH
Ann Neurol; 1990 Aug; 28(2):168-73. PubMed ID: 2221845
[TBL] [Abstract][Full Text] [Related]
13. Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis.
Gieffers J; Pohl D; Treib J; Dittmann R; Stephan C; Klotz K; Hanefeld F; Solbach W; Haass A; Maass M
Ann Neurol; 2001 May; 49(5):585-9. PubMed ID: 11357948
[TBL] [Abstract][Full Text] [Related]
14. [Neurofilament protein light in multiple sclerosis].
Zhang Y; Li X; Qiao J
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2745-9. PubMed ID: 18167263
[TBL] [Abstract][Full Text] [Related]
15. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
Link H; Huang YM
J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide as an activity marker in multiple sclerosis.
Acar G; Idiman F; Idiman E; Kirkali G; Cakmakçi H; Ozakbaş S
J Neurol; 2003 May; 250(5):588-92. PubMed ID: 12736739
[TBL] [Abstract][Full Text] [Related]
17. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H
Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
[TBL] [Abstract][Full Text] [Related]
18. Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS.
Sellebjerg F; Börnsen L; Khademi M; Krakauer M; Olsson T; Frederiksen JL; Sørensen PS
Neurology; 2009 Dec; 73(23):2003-10. PubMed ID: 19996075
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid levels of iodothyronines and nerve growth factor in patients with multiple sclerosis and neuromyelitis optica.
Jiang Y; Yang Y; Zhang B; Peng F; Bao J; Hu X
Neuro Endocrinol Lett; 2009 Mar; 30(1):85-90. PubMed ID: 19300400
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal origin of CSF ribonuclease. Differences between infectious processes of the nervous system and multiple sclerosis.
Allinquant B; Musenger C; Schuller E
Acta Neurol Scand; 1984 Jul; 70(1):12-9. PubMed ID: 6206680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
